Quick Answer
CV Sciences, Inc. reported Cash and Equivalents of $611.0 thousand for fiscal year 2022.
CV Sciences, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2022 | $611.0K | -55.6% |
| 2021 | $1.38M | -65.8% |
| 2020 | $4.02M | -55.8% |
| 2019 | $9.11M | -28.2% |
| 2018 | $12.68M | +450.9% |
| 2014 | $2.30M | +2.6% |
| 2013 | $2.24M | +520473.1% |
| 2012 | $431.00 | -63.1% |
| 2011 | $1.2K | -96.2% |
| 2010 | $30.7K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2022 | $1.14M | — | +2.2% |
| June 30, 2022 | $1.11M | -54.7% | -54.3% |
| March 31, 2022 | $2.44M | -52.8% | +77.4% |
| December 31, 2021 | $1.38M | — | -44.1% |
| June 30, 2021 | $2.46M | — | -52.4% |
| March 31, 2021 | $5.17M | — | +3168611.7% |
| September 30, 2012 | $163.00 | -99.0% | +44.2% |
| June 30, 2012 | $113.00 | -98.2% | -46.7% |
- CV Sciences, Inc. showed a decrease of -55.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2010–2022 period, CV Sciences, Inc.’s cash and equivalents has grown by 1890.2% (from $30.7 thousand to $611.0 thousand).
- The most recent figure is from CV Sciences, Inc.’s fiscal year 2022 report (Form 10-K), filed with the SEC on March 30, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: